Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.6700 (-0.84%) ($23.6700 - $24.4400) on Wed. May. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 87 | Latest Price | $23.6700(-0.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 8.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(49%) IWM(45%) ARKG(43%) IWC(43%) | Factors Impacting HALO price | HALO will decline at least -2.105% in a week (0% probabilities). VIXM(-31%) VXX(-14%) UUP(-14%) TLT(-3%) IYT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
5 Day Moving Average | $23.44(0.98%) | 10 Day Moving Average | $23.27(1.72%) | 20 Day Moving Average | $21.18(11.76%) | To recent high | -0.8% | To recent low | 70.3% | Market Cap | $3.235b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |